Interferon-α enhances NK cell function to counteract autologous platelet-mediated tumor immune evasion.
Saved in:
| Title: | Interferon-α enhances NK cell function to counteract autologous platelet-mediated tumor immune evasion. |
|---|---|
| Authors: | Wang LT; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Shih CC; Graduate Institute of Medical Sciences, National Defense Medical University, Taipei, Taiwan.; Department of Pharmacology, National Defense Medical University, Taipei, Taiwan., Chen YH; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Laboratory of Clinical Immunology, National Defense Medical University, Taipei, Taiwan., Chang CF; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Laboratory of Clinical Immunology, National Defense Medical University, Taipei, Taiwan., Fan HL; Division of Organ Transplantation Surgery, Department of Surgery, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan., Chen TW; Division of Organ Transplantation Surgery, Department of Surgery, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan., Chen YW; Graduate Institute of Medical Sciences, National Defense Medical University, Taipei, Taiwan.; Department of Pharmacology, National Defense Medical University, Taipei, Taiwan., Krupalakshmi S; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Lin YF; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Shih YL; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Laboratory of Clinical Immunology, National Defense Medical University, Taipei, Taiwan., Hsieh TY; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Laboratory of Clinical Immunology, National Defense Medical University, Taipei, Taiwan., Huang WY; Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Huang WC; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, Taipei, Taiwan. weichen@mail.ndmctsgh.edu.tw.; Laboratory of Clinical Immunology, National Defense Medical University, Taipei, Taiwan. weichen@mail.ndmctsgh.edu.tw.; Division of Gastroenterology, Department of Internal Medicine, Tri- Service General Hospital, National Defense Medical University, No.325, Sec.2, Chenggong Rd., Neihu District, Taipei, 114202, Taiwan. weichen@mail.ndmctsgh.edu.tw. |
| Source: | Cancer cell international [Cancer Cell Int] 2026 Jan 23; Vol. 26 (1), pp. 92. Date of Electronic Publication: 2026 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867 (Print) Linking ISSN: 14752867 NLM ISO Abbreviation: Cancer Cell Int Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
